Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Suppl
|
pubmed:dateCreated |
1994-3-14
|
pubmed:abstractText |
Although computed tomography and magnetic resonance imaging have improved the staging and evaluation of non-small cell lung cancer (NSCLC), mediastinal staging lacks adequate specificity and sensitivity. Radioimmunodetection may augment computed tomography and magnetic resonance imaging. The authors evaluated the ability of the technetium 99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment to localize NSCLC in vivo, measured its pharmacokinetics, and estimated its radiation dose.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
890-5
|
pubmed:dateRevised |
2011-8-1
|
pubmed:meshHeading |
pubmed-meshheading:8306275-Antibodies, Monoclonal,
pubmed-meshheading:8306275-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8306275-Immunoglobulin Fab Fragments,
pubmed-meshheading:8306275-Lung Neoplasms,
pubmed-meshheading:8306275-Radioimmunodetection,
pubmed-meshheading:8306275-Technetium,
pubmed-meshheading:8306275-Tomography, Emission-Computed
|
pubmed:year |
1994
|
pubmed:articleTitle |
Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
|
pubmed:affiliation |
Division of Nuclear Medicine, New York University Medical Center, NY 10016.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|